Skip to main content

Table 1 Characteristics of cervical cancer patients with AC and SCC before and after matching

From: Comparison of survival outcomes of locally advanced cervical cancer by histopathological types in the surveillance, epidemiology, and end results (SEER) database: a propensity score matching study

Characteristics

Before matching

 

After matching

 

AC (n = 746)

SCC (n = 3385)

P value

AC(n = 676)

SCC(n = 676)

P value

age (%)

  

0.02

  

0.872

  < 40

158 (21.2)

840 (24.8)

146 (21.6)

143 (21.2)

 40–49

253 (33.9)

965 (28.5)

222 (32.8)

236 (34.9)

 50–59

199 (26.7)

947 (28.0)

183 (27.1)

179 (26.5)

 60–69

136 (18.2)

633 (18.7)

125 (18.5)

118 (17.5)

race (%)

  

< 0.001

  

0.763

 Black

59 (7.9)

568 (16.8)

58 (8.6)

62 (9.2)

 

 White

596 (79.9)

2476 (73.1)

538 (79.6)

527 (78.0)

 Other

91 (12.2)

341 (10.1)

80 (11.8)

87 (12.9)

 

grade (%)

  

< 0.001

  

0.928

 I

138 (18.5)

142 (4.2)

 

80 (11.8)

77 (11.4)

 

 II

313 (42.0)

1610 (47.6)

306 (45.3)

297 (43.9)

 III

265 (35.5)

1583 (46.8)

264 (39.1)

276 (40.8)

 IV

30 (4.0)

50 (1.5)

 

26 (3.8)

26 (3.8)

 

FIGO stage (%)

  

< 0.001

  

0.923

 Ib2

142 (19.0)

366 (10.8)

118 (17.5)

121 (17.9)

 IIa1

25 (3.4)

81 (2.4)

 

21 (3.1)

14 (2.1)

 

 IIa2

42 (5.6)

135 (4.0)

 

35 (5.2)

38 (5.6)

 

 IIb

160 (21.4)

732 (21.6)

142 (21.0)

143 (21.2)

 IIIa

15 (2.0)

75 (2.2)

 

14 (2.1)

11 (1.6)

 

 IIIb

346 (46.4)

1837 (54.3)

331 (49.0)

333 (49.3)

 IVa

16 (2.1)

159 (4.7)

 

15 (2.2)

16 (2.4)

 

sequence (%)

  

< 0.001

  

0.974

 No surgery

318 (42.6)

2011 (59.4)

308 (45.6)

302 (44.7)

 RPTS

55 (7.4)

133 (3.9)

 

45 (6.7)

48 (7.1)

 

 RAS

365 (48.9)

1218 (36.0)

315 (46.6)

317 (46.9)

 RBAS

8 (1.1)

23 (0.7)

 

8 (1.2)

9 (1.3)

 

Radiation (%)

  

0.527

  

0.25

 Beam radiation

328 (44.0)

1487 (43.9)

294 (43.5)

323 (47.8)

 brachytherapy

82 (11.0)

328 (9.7)

 

70 (10.4)

70 (10.4)

 

 BRB

336 (45.0)

1570 (46.4)

312 (46.2)

283 (41.9)

Chemotherapy (%)

  

0.017

  

0.865

 Yes

652(87.4)

3060(90.4)

 

596(88.2)

599(88.6)

 

 No

94 (12.6)

325 (9.6)

 

80 (11.8)

77 (11.4)

 

status (%)

  

0.055

   

 alive

535 (71.7)

2303 (68.0)

480 (71.0)

486 (71.9)

0.763

dead

211(28.3)

1082(32.0)

 

196(29.0)

190(28.1)

 

time (mean (SD))

35.8(21.4)

33.6(21.7)

0.013

35.0(21.1)

33.7 (21.5)

0.269

  1. AC adenocarcinoma, SCC Squamous cell carcinoma, FIGO the International Federation of Gynecology and Obstetrics, RPTS Radiation prior to surgery, RAS Radiation after surgery, RBAS Radiation before and after surgery, BRB Combination of beam with brachytherapy. Grade I Well differentiated,gradeII Moderately differentiated,gradeIII Poorly differentiated,gradeIV Undifferentiated;SD Standard Deviation